Kailash Pant
Interventional Cardiology · Deland, FLNPI 1558857110
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Abbott at 38.4% of the total. 2025 is the largest year on record at $5,729, 8.8 times the $649 reported in 2021.
Across 109 payments — averaging $97.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Abiomed$2K
- Edwards Lifesciences$2K
- Johnson & Johnson$659
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$543
- Medtronic$275
- plus $1K from 17 others
What the payments were for
- Travel & lodging$4,51642%
- Food & beverage$6,06557%
- Education$701%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 33 | $4,086 |
| Abiomed | 14 | $2,048 |
| Edwards Lifesciences | 14 | $1,666 |
| Johnson & Johnson | 8 | $659 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $543 |
| Medtronic | 4 | $275 |
| Shockwave Medical, Inc | 2 | $145 |
| Livanova USA, Inc. | 2 | $133 |
| Penumbra, Inc. | 1 | $129 |
| Intuitive Surgical | 1 | $117 |
| Boehringer Ingelheim | 1 | $114 |
| Philips North America LLC | 1 | $113 |
| Teleflex LLC | 1 | $96 |
| Getinge USA Sales, LLC | 4 | $85 |
| Biosense Webster, Inc. | 1 | $83 |
| Novo Nordisk | 1 | $82 |
| E.r. Squibb & Sons, L.L.C. | 1 | $76 |
| Pfizer | 3 | $58 |
| Novartis | 2 | $45 |
| Cordis US CORP. | 2 | $36 |
| Bayer | 1 | $26 |
| Amgen | 1 | $17 |
| Kestra Medical Technology Services, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$1,567
- PROSTAR$1,528
- OPTIS$633
- SAPIEN 3 Ultra RESILIA$571
- XARELTO$365
- LifeVest$216
- GALLANT$209
- SUPERA$178
- Indigo System$129
- LifeSPARC$126
- Da Vinci Surgical System$117
- MERLIN@HOME$114
- JARDIANCE$114
- (6342) Intrasight Integ$113
- DRAGONFLY OPSTAR$111
How this compares
$10,650 in reported general payments places this provider in the 55th percentile of 623 interventional cardiology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 17 | $15,060 |
| ClopidogrelClopidogrel Bisulfate | 58 | $844 |
| Metoprolol Succinate | 17 | $167 |
| Spironolactone | 16 | $101 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Deland
- Arthur LeeGainesville$1.8M
- Santhosh MathewsBradenton$1.4M
- Siddharth WayangankarJacksonville$1.2M
- Patrick CambierTrinity$901K
- Zahid AminOrlando$635K
- Rohit AminPensacola$560K
- Eduardo de MarchenaMiami$498K
- Dominick AngiolilloJacksonville$387K
- Miguel DiazHialeah$383K
- Douglas EbersoleLakeland$373K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.